Outpatient treatment of pelvic inflammatory disease (PID), a leading cause of infertility in women, is just as effective as inpatient treatment, concludes a long-term study funded by the Agency for Healthcare Research and Quality (AHRQ). The findings may obviate standard 48-hour hospital stays for 85 000 women annually.
The PID Evaluation and Clinical Health (PEACH) study followed up 823 women for 35 months. Half the patients received treatment in a hospital that included several intravenous doses of cefoxitin plus doxycycline. The other, outpatient, half received a single intramuscular injection of cefoxitin and an oral dose of probenecid, followed by 2 weeks of oral doxycycline.
Vastag B. Outpatient PID Treatment Works. JAMA. 2002;287(23):3070. doi:10.1001/jama.287.23.3070-JHA20006-3-1